⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of BioScience Communications and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
BioScience Communications
↗New York, NY, USA
BioScience Communications is a specialized medical communications agency that functions as a division of Daniel J. Edelman, Inc. (DJE Holdings). The firm provides strategic medical communications, publication planning, science writing, and creative visualization services to biopharmaceutical, medical device, and emerging biotechnology companies.
Founded in 1995, the company bridges the gap between complex scientific data and various stakeholders, including healthcare professionals, regulators, and patient advocates. Their services encompass FDA advisory committee preparation, medical congress support, and peer-to-peer educational initiatives, all grounded in clinical evidence and regulatory compliance.
CLASSIFICATION
SIZE & FINANCIALS
Employees:21-50
Revenue:$35M
Founded:1995
Ownership:subsidiary
Status:operating
0
CORPORATE STRUCTURE
Parent Company:Daniel J. Edelman, Inc. (DJE Holdings)
Acquired By:Daniel J. Edelman, Inc. (DJE Holdings)
Key Partnerships:Daniel J. Edelman, Inc. (Parent), Biopharmaceutical and medical device companies (Client base)
COMPETITION
Position:Niche Player
Competitors:Alligent Group, Envision Pharma Group, Evaluate
LEADERSHIP
Key Executives:
Catherine Grillo - Medical Director
LINKS
Website:bioscicom.net
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with BioScience Communications. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.